Market Place
Sourcing Support
Supreme Court Asks Zydus to Approach Delhi HC Over Sigrima Ban
19 Nov 2024 //
ECONOMICTIMES
India`s Zydus Life posts Q2 profit rise on steady US demand
12 Nov 2024 //
REUTERS
Zydus Lifesciences Reports 14% Profit Rise, 22% R&D Increase
12 Nov 2024 //
FINANCIALXPRESS
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
Zydus gets WHO nod for its typhoid vaccine
23 Oct 2024 //
ECONOMICTIMES
Zydus Receives WHO Acceptability For ZyVac TCV For UN Purchases
23 Oct 2024 //
EXPRESSPHARMA
Zydus gains FDA approval for Fludrocortisone Acetate Tablets
18 Oct 2024 //
EXPRESSPHARMA
Zydus and ICMR Start Phase 2 Trial of Desidustat for Sickle Cell
15 Oct 2024 //
INDPHARMAPOST
High Court refuses interim injunction against Zydus cancer drug
11 Oct 2024 //
PHARMABIZ
Zydus gets US nod for schizophrenia generic medicine
11 Oct 2024 //
ECONOMICTIMES
Zydus Lifesciences Receives FDA Warning Letter
09 Oct 2024 //
FDA
UBS advises `selling` a bunch of pharma stocks
27 Sep 2024 //
CNBCTV
Zydus and CSIR-CDRI to develop drug for CKD induced Osteoporosis
27 Sep 2024 //
INDPHARMAPOST
Zydus Lifesciences Acquires API Business Of Sterling Biotech For Rs 84 Crore
17 Sep 2024 //
MONEYCONTROL
FDA Warning Letter To India`s Zydus Flags Glass Contamination Concerns
12 Sep 2024 //
ENDPTS
Zydus Lifesciences Receives FDA Warning Letter
10 Sep 2024 //
FDA
Zydus gains final USFDA tentative approval for Amantadine ER capsule
03 Sep 2024 //
EXPRESSPHARMA
Zydus Lifesciences gets USFDA nod to market Scopolamine transdermal system
30 Aug 2024 //
ECONOMICTIMES
Zydus Lifesciences Gets Warning Letter From USFDA For Jarod Injectable Unit
30 Aug 2024 //
ECONOMICTIMES
Zydus`s Generics Scopolamine Receives Approval in US
29 Aug 2024 //
FDA
Zydus Lifesciences gets USFDA nod for generic medication
29 Aug 2024 //
CONTRACT PHARMA
Zydus`s Generics Amantadine Receives Approval in US
26 Aug 2024 //
FDA
Zydus To Acquire 50% Stake In Sterling Biotech From Perfect Day
23 Aug 2024 //
ECONOMICTIMES
Zydus Lifesciences to scale up US specialties business
19 Aug 2024 //
INDIANPHARMAPOST
Zydus Lifesciences Q1 FY25 revenue up 21% YoY to reach Rs. 6,207.5 Cr
11 Aug 2024 //
INDIANPHARMAPOST
Zydus gains final USFDA approval for Valbenazine Capsules
09 Aug 2024 //
EXPRESSPHARMA
India`s Zydus Lifesciences Q1 profit beats estimates on strong US demand
08 Aug 2024 //
REUTERS
Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyout
08 Aug 2024 //
ECONOMICTIMES
Zydus gets Mexican regulatory approval to market cancer treatment product
31 Jul 2024 //
ECONOMICTIMES
Zydus Lifesciences gets Mexican regulatory nod for cancer treatment biosimilar
22 Jul 2024 //
ECONOMICTIMES
Zydus signs patent licensing agreement with Takeda for `VaultA’ in India
19 Jul 2024 //
INDIANPHARMAPOST
Zydus Life hits 52-week high on USFDA nod for Sacubitril and Valsartan
11 Jul 2024 //
ECONOMIC TIMES
Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug
05 Jul 2024 //
ECONOMIC TIMES
Zydus and Dr. Reddy`s announce agreement for marketing of Pertuzumab biosimilar
29 Jun 2024 //
PRESS RELEASE
Zydus to make Biotax 1g injection available in Nepal
19 Jun 2024 //
ECONOMICTIMES
Zydus Receives Tentative USFDA Approval For Hypertension Tablets
14 Jun 2024 //
INDIANPHARMAPOST
Sentynl Therapeutics Receives Great Place To Work® Certification
03 Jun 2024 //
PR NEWSWIRE
Zydus Lifesciences net jumps to Rs. 1,182 crore in Q4, dividend at 300%
29 May 2024 //
PHARMABIZ
Zydus receives final approval from USFDA for Theophylline ER Tablets
25 May 2024 //
INDIANPHARMAPOST
Zydus announces completion of Enrolment for Phase II clinical trial of Usnoflast
25 May 2024 //
INDIANPHARMAPOST
Zydus Lifesciences gets USFDA nod for asthma treatment drug
22 May 2024 //
ECONOMICTIMES
Zydus receives final approval from USFDA for Dexamethasone Tablets
13 May 2024 //
INDINPHARMAPOST
SEC recommends approval for Zydus Lifesciences` trivalent influenza vaccine
08 May 2024 //
PHARMABIZ
FDA issues another Form 483 reprimand for drugmaker Zydus
07 May 2024 //
FIERCE PHARMA
Zydus unit acquires global rights to Eiger BioPharma’s Zokinvy
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
03 May 2024 //
PR NEWSWIRE
FDA Issues form 483 to Zydus Life sciences
30 Apr 2024 //
FDA
Zydus Lifesciences gets 10 observations from USFDA for Jarod injectable facility
24 Apr 2024 //
INDINPHARMAPOST
Zydus launches Mirabegron Extended-Release Tablets in the US
22 Apr 2024 //
BUSINESSWIRE
FDA Issues Form 483 to Zydus Lifesciences
12 Apr 2024 //
FDA
WHO INN approves ‘Usnoflast’ as recommended name for ZYIL1 from Zydus
01 Apr 2024 //
EXPRESS PHARMA
Zydus Lifesciences gets 4 observations from USFDA for Gujarat plant
28 Mar 2024 //
BUSINESS STANDARD
Zydus launches anti-cancer generic drug olaparib in India
13 Mar 2024 //
ECONOMIC TIMES
Zydus aims to launch first new drug in US by early 2026
27 Feb 2024 //
ECONOMIC TIMES
Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain
16 Feb 2024 //
ECONOMIC TIMES
India`s Zydus Lifesciences beats Q3 profit estimates; approves shares buyback
09 Feb 2024 //
REUTERS
Zydus Lifesciences launches Rexigo
01 Feb 2024 //
INDIAN PHARMA POST
Zydus launches pill for prostate cancer patients
30 Jan 2024 //
ECONOMIC TIMES
Zydus gets USFDA nod for generic medication
25 Jan 2024 //
ECONOMIC TIMES
Zydus Lifesciences arm gets Rs 284.58 cr income tax demand notice
26 Dec 2023 //
ECONOMIC TIMES
